Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052] - Université de Lorraine Access content directly
Journal Articles Journal of Stroke and Cerebrovascular Diseases Year : 2021

Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052]

Sébastien Richard

Dates and versions

hal-03280247 , version 1 (07-07-2021)

Identifiers

Cite

Solène Hebert, Pierre Clavel, Benjamin Maier, Katsuhiro Mizutani, François Delvoye, et al.. Corrigendum to ‘Benefits and Safety of Periprocedural Heparin During Thrombectomy in Patients Contra-Indicated for Alteplase’ [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 10 (October), 2020: 105052]. Journal of Stroke and Cerebrovascular Diseases, 2021, 30 (2), pp.105465. ⟨10.1016/j.jstrokecerebrovasdis.2020.105465⟩. ⟨hal-03280247⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More